Microenvironmental M1 tumor-associated macrophage polarization influences cancer-related anemia in advanced ovarian cancer: key role of interleukin-6.
作者信息
Madeddu Clelia, Gramignano Giulia, Kotsonis Paraskevas, Coghe Ferdinando, Atzeni Vinicio, Scartozzi Mario, Macciò Antonio
机构信息
Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.
Medical Oncology Unit, San Gavino Hospital, San Gavino.
出版信息
Haematologica. 2018 Sep;103(9):e388-e391. doi: 10.3324/haematol.2018.191551. Epub 2018 Apr 19.
Abstract
摘要
相似文献
1
Microenvironmental M1 tumor-associated macrophage polarization influences cancer-related anemia in advanced ovarian cancer: key role of interleukin-6.
Haematologica. 2018 Sep;103(9):e388-e391. doi: 10.3324/haematol.2018.191551. Epub 2018 Apr 19.
2
MiR-217 Inhibits M2-Like Macrophage Polarization by Suppressing Secretion of Interleukin-6 in Ovarian Cancer.
Inflammation. 2019 Oct;42(5):1517-1529. doi: 10.1007/s10753-019-01004-2.
3
Altered monocyte differentiation and macrophage polarization patterns in patients with breast cancer.
BMC Cancer. 2018 Apr 3;18(1):366. doi: 10.1186/s12885-018-4284-y.
4
Astragaloside IV antagonizes M2 phenotype macrophage polarization-evoked ovarian cancer cell malignant progression by suppressing the HMGB1-TLR4 axis.
Mol Immunol. 2021 Feb;130:113-121. doi: 10.1016/j.molimm.2020.11.014. Epub 2020 Dec 9.
5
Determination of Polarization of Resident Macrophages and Their Effect on the Tumor Microenvironment.
Methods Mol Biol. 2019;1928:101-112. doi: 10.1007/978-1-4939-9027-6_7.
6
Diverse macrophages polarization in tumor microenvironment.
Arch Pharm Res. 2016 Nov;39(11):1588-1596. doi: 10.1007/s12272-016-0820-y. Epub 2016 Aug 25.
7
Macrophage Polarization States in the Tumor Microenvironment.
Int J Mol Sci. 2021 Jun 29;22(13):6995. doi: 10.3390/ijms22136995.
8
Influence of hypoxia inducible factors on the immune microenvironment in ovarian cancer.
Anticancer Res. 2014 Jun;34(6):2811-9.
9
DFMO and 5-Azacytidine Increase M1 Macrophages in the Tumor Microenvironment of Murine Ovarian Cancer.
Cancer Res. 2019 Jul 1;79(13):3445-3454. doi: 10.1158/0008-5472.CAN-18-4018. Epub 2019 May 14.
10
Head and neck squamous cell carcinoma cell lines have an immunomodulatory effect on macrophages independent of hypoxia and toll-like receptor 9.
BMC Cancer. 2021 Sep 3;21(1):990. doi: 10.1186/s12885-021-08357-8.
引用本文的文献
1
Divergent Immune-Metabolic Profiles in Endometriosis and Ovarian Cancer: A Cross-Sectional Analysis.
Cancers (Basel). 2025 Jul 12;17(14):2325. doi: 10.3390/cancers17142325.
2
Disparate Roles of Cell-Cell Contact and Cytokine Secretion in an In Vitro Model of the Seminoma Microenvironment.
Int J Mol Sci. 2025 Jun 26;26(13):6173. doi: 10.3390/ijms26136173.
3
The role of macrophage polarization in ovarian cancer: from molecular mechanism to therapeutic potentials.
Front Immunol. 2025 Apr 22;16:1543096. doi: 10.3389/fimmu.2025.1543096. eCollection 2025.
4
Cancer is not a guest.
Transl Oncol. 2025 Jan;51:102162. doi: 10.1016/j.tranon.2024.102162. Epub 2024 Oct 28.
5
New hopes and promises in the treatment of ovarian cancer focusing on targeted treatment-a narrative review.
Front Pharmacol. 2024 Jun 14;15:1416555. doi: 10.3389/fphar.2024.1416555. eCollection 2024.
6
TLR3 agonism augments CD47 inhibition in acute myeloid leukemia.
Haematologica. 2024 Jul 1;109(7):2111-2121. doi: 10.3324/haematol.2023.283850.
7
Defining the Role of Metastasis-Initiating Cells in Promoting Carcinogenesis in Ovarian Cancer.
Biology (Basel). 2023 Dec 5;12(12):1492. doi: 10.3390/biology12121492.
8
Synergistic immunotherapy targeting cancer-associated anemia: prospects of a combination strategy.
Cell Commun Signal. 2023 May 19;21(1):117. doi: 10.1186/s12964-023-01145-w.
9
Nanomedicine Strategies for Heating "Cold" Ovarian Cancer (OC): Next Evolution in Immunotherapy of OC.
Adv Sci (Weinh). 2022 Oct;9(28):e2202797. doi: 10.1002/advs.202202797. Epub 2022 Jul 22.
10
EGFR-Mutated Non-Small Cell Lung Cancer and Resistance to Immunotherapy: Role of the Tumor Microenvironment.
Int J Mol Sci. 2022 Jun 10;23(12):6489. doi: 10.3390/ijms23126489.
本文引用的文献
1
Lactoferrin Efficiently Counteracts the Inflammation-Induced Changes of the Iron Homeostasis System in Macrophages.
Front Immunol. 2017 Jun 15;8:705. doi: 10.3389/fimmu.2017.00705. eCollection 2017.
2
Treatment with anti-IL-6 receptor antibody prevented increase in serum hepcidin levels and improved anemia in mice inoculated with IL-6-producing lung carcinoma cells.
BMC Cancer. 2016 Apr 11;16:270. doi: 10.1186/s12885-016-2305-2.
3
Modulation of human monocyte/macrophage activity by tocilizumab, abatacept and etanercept: An in vitro study.
Eur J Pharmacol. 2016 Jun 5;780:33-7. doi: 10.1016/j.ejphar.2016.03.028. Epub 2016 Mar 17.
4
Macrophages and Iron Metabolism.
Immunity. 2016 Mar 15;44(3):492-504. doi: 10.1016/j.immuni.2016.02.016.
5
The role of inflammation, iron, and nutritional status in cancer-related anemia: results of a large, prospective, observational study.
Haematologica. 2015 Jan;100(1):124-32. doi: 10.3324/haematol.2014.112813. Epub 2014 Sep 19.
6
The iron-regulatory hormone hepcidin: a possible therapeutic target?
Pharmacol Ther. 2015 Feb;146:35-52. doi: 10.1016/j.pharmthera.2014.09.004. Epub 2014 Sep 7.
7
Macrophage activation and polarization: nomenclature and experimental guidelines.
Immunity. 2014 Jul 17;41(1):14-20. doi: 10.1016/j.immuni.2014.06.008.
8
Metabolic reprogramming of macrophages: glucose transporter 1 (GLUT1)-mediated glucose metabolism drives a proinflammatory phenotype.
J Biol Chem. 2014 Mar 14;289(11):7884-96. doi: 10.1074/jbc.M113.522037. Epub 2014 Feb 3.
9
Orchestration of metabolism by macrophages.
Cell Metab. 2012 Apr 4;15(4):432-7. doi: 10.1016/j.cmet.2011.11.013.
10
The investigation and treatment of secondary anaemia.
Blood Rev. 2012 Mar;26(2):65-71. doi: 10.1016/j.blre.2011.10.003. Epub 2011 Dec 1.
Zotero 插件